Research Article
Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection
Figure 3
DCs and monocytes at baseline according to the response to IFN-based therapy: 13 responders (R), 4 non responders for virological failure (nRv), and 8 non responders for side effects (nRse). , , and .